LIMITATION OF PATIENT EXPOSURE TO RADIATION FROM EMERGING MEDICAL DIAGNOSTIC PROCEDURES IN HIGH MORBILITY DISEASE AREAS

Ziel

ESTABLISHMENT OF PROTOCOLS FOR DISEASE SPECIFIC DIAGNOSIS AND EXPOSURE REDUCTION; SPECIFICITY AND SENSITIVITY OF VARIOUS DIAGNOSTIC METHODS.
Comparisons have been made of nuclear cardiology versus 2-dimensional echocardiography for the detection, quantitation and follow up study of myocardial disease.
The diagnostic efficacy of immunoscintigraphy with radioactive monoclonal antibodies has been compared to that of bidimensional echography.

The role of functional indices, derived from radionuclide angiography (RNA), to diagnose early myocardial disease in patients with ventricular arrhythmias and/or left bundle branch block (LBBB), but without clinical evidence of heart failure or other cardiac and systemic diseases, has been assessed in comparison with radiological invasive, and nonradiological noninvasive procedures. The presence of organ specific cardiac autoantibodies was checked, in view of developments in the field of radioimmunoscintigraphy of myocardial disease.
DEVELOPMENT AND TESTING OF ADEQUATELY ASSESSED, RELIABLE AND AGREED PROTOCOLS DEFINING THE ACTUAL DIAGNOSTIC EFFICACY OF:
1. NUCLEAR CARDIOLOGY PROCEDURES (VERSUS BIDIMENSIONAL ECHOCARDIOGRAPHY).
2. IMMUNOSCINTIGRAPHY WITH RADIOACTIVE MONOCLONAL ANTIBODIES (VERSUS BIDIMENSIONAL ECHOGRAPHY).

Wissenschaftliches Gebiet

Programm/Programme

FP1-RADPROT 6C - Multiannual research and training programme (Euratom) in the field of radiation protection, 1985-1989

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CSC - Cost-sharing contracts

Koordinator

Università degli Studi di Pisa

EU-Beitrag

Keine Daten

Adresse

Lungarno Pacinotti 45
56100 Pisa
Italien

Gesamtkosten